We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5076:TSEINFRONEER Holdings Inc. Analysis

Data as of 2026-03-15 - not real-time

¥2,287.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

INFRONEER Holdings trades at roughly ¥2,287, well below the DCF‑derived fair value of about ¥5,050 and a PE multiple of 13.9 versus an industry average of 29.1, indicating a strong undervaluation. The company is delivering rapid top‑line expansion, with revenue growing around 54% year‑over‑year, while maintaining a healthy dividend yield of 4% and a modest payout ratio of 36%, supporting dividend sustainability. Balance‑sheet strength is highlighted by a cash pile exceeding ¥198 billion, offsetting a high debt load and resulting in a net‑debt‑to‑equity profile that remains manageable given cash resources.
Technical signals show the price hovering just above the identified support level of ¥2,264 and below the 20‑day SMA of ¥2,495, with an RSI near 37 suggesting near‑oversold conditions. Although the MACD histogram is negative, the overall trend is classified as bullish, and the low beta (~0.03) points to limited market‑wide volatility, even as 30‑day price swings sit near 35%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with limited upside to resistance
  • Bullish SMA crossover despite bearish MACD histogram
  • RSI approaching oversold territory, hinting at potential rebound

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Robust revenue growth exceeding 50% and attractive dividend yield
  • Stable liquidity and low beta reducing market‑wide exposure

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term infrastructure demand in Japan supporting sustainable earnings
  • Consistent dividend policy with comfortable payout ratio
  • Strong cash position offsetting debt, enabling continued investment and dividend payments

Key Metrics & Analysis

Financial Health

Revenue Growth53.90%
Profit Margin6.25%
P/E Ratio13.9
ROE11.38%
ROA2.30%
Debt/Equity105.50
P/B Ratio1.0
Op. Cash Flow¥65.9B
Free Cash Flow¥-81430249472
Industry P/E29.1

Technical Analysis

TrendBullish
RSI37.2
Support¥2,264.00
Resistance¥2,670.50
MA 20¥2,495.28
MA 50¥2,393.42
MA 200¥1,742.75
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value¥5,051.47
Target Price¥2,415.71
Upside/Downside5.63%
GradeUndervalued
TypeGrowth
Dividend Yield4.02%

Risk Assessment

Beta0.03
Volatility35.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.